News >

Checkpoint Blockade Therapy Clears Safety Hurdle for Patients With HIV and Cancer

Lisa Astor
Published: Thursday, Jan 25, 2018

 Thomas S. Uldrick, MD

Thomas S. Uldrick, MD
Although there has been reluctance among oncology researchers to administer immunotherapy to patients with HIV who develop cancer, early signals from a small clinical trial suggest that such a strategy may be safe in certain settings.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication